“Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Regional Differences in Baseline Disease Characteristics and Prior Treatment in the ECZTRA 1 and ECZTRA 2 Trials” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s101. doi:10.25251/skin.4.supp.101.